An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
NCT01096979 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-03-26
Summary
This is a double-masked evaluation of the safety and efficacy of LIPO-102 for the reduction of subcutaneous abdominal adiposity.
Conditions
- Subcutaneous Abdominal Adiposity
Interventions
- DRUG
-
LIPO-102
subcutaneous injection
- DRUG
-
Placebo
Sponsors & Collaborators
-
Neothetics, Inc
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
NCT02483533 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
NCT03005717 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
NCT01853397 ·Status: COMPLETED ·Phase: NA
-
Dose Ranging Study
NCT01802723 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")
NCT04258761 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NCT06500429 ·Status: COMPLETED ·Phase: PHASE2
-
A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
NCT01044108 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of LY3457263 in Obese Participants
NCT05582096 ·Status: COMPLETED ·Phase: PHASE1
-
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
NCT03041792 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
NCT05760248 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
NCT05154955 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of TG103 Injection in Overweight or Obesity
NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of SODB® in Metabolic Adaptations in Overweight Women
NCT02667691 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
NCT03523273 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of LY3305677 in Participants With Obesity Or Overweight
NCT05623839 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3537021 in Healthy Participants
NCT05444569 ·Status: COMPLETED ·Phase: PHASE1
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
NCT06143956 ·Status: RECRUITING ·Phase: PHASE2
-
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
NCT02963935 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
NCT02970942 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
NCT06326060 ·Status: COMPLETED ·Phase: PHASE2